News

The company said the move will enable it to focus its resources on the advancement of HspE7 for human papillomavirus (HPV)-related diseases. As a result of the restructuring,

The agreement, which was announced on December 15, 2004, remains subject to European and US regulatory review, as well as other customary closing conditions. The terms of the

The final approval of the generic 500mg, 750mg and 1000mg Niaspan tablets follows the expiration of Kos’ 30-month stay under the Hatch-Waxman patent challenge provisions and the resolution

These collaborations will utilize ParAllele’s application-specific single nucleotide polymorphism (SNP) genotyping panel that is being commercialized as part of an existing development partnership with Affymetrix. The new panel

The study was designed to evaluate the pharmacokinetic (PK) profiles of various doses of NovaDel’s lingual spray compared to a 0.5mg alprazolam tablet (Xanax). NovaDel achieved its goal

The primary task of the study is to evaluate the biodistribution of indomethacin, the active ingredient in Indaflex, after either oral or topical administration of appropriate formulations in

ISIS 369645 is a second-generation antisense inhibitor of the alpha subunit of the interleukin 4 receptor, IL4R-alpha. Inhibiting the production of the IL4R-alpha inhibits the activity of two

The Aeras Global TB Vaccine Foundation is an international non-governmental organization currently funded by the Bill & Melinda Gates Foundation and the US Centers for Disease Control and

MPC-6827 is being developed by Myriad from a family of anticancer analogs discovered by Maxim through its proprietary high-throughput screening system, which identifies compounds and molecular targets that